FIDSON Stock Overview
Fidson Healthcare Plc engages in the manufacture and distribution of pharmaceutical products in Nigeria.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Fidson Healthcare Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦15.90 |
| 52 Week High | ₦19.20 |
| 52 Week Low | ₦8.50 |
| Beta | 0.030 |
| 1 Month Change | 6.00% |
| 3 Month Change | -11.67% |
| 1 Year Change | 76.67% |
| 3 Year Change | 306.74% |
| 5 Year Change | 284.40% |
| Change since IPO | 455.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| FIDSON | NG Pharmaceuticals | NG Market | |
|---|---|---|---|
| 7D | 0% | 0.1% | -3.9% |
| 1Y | 76.7% | 13.2% | 120.5% |
Return vs Industry: FIDSON exceeded the NG Pharmaceuticals industry which returned 15.3% over the past year.
Return vs Market: FIDSON underperformed the NG Market which returned 122% over the past year.
Price Volatility
| FIDSON volatility | |
|---|---|
| FIDSON Average Weekly Movement | 4.7% |
| Pharmaceuticals Industry Average Movement | 4.2% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in NG Market | 11.8% |
| 10% least volatile stocks in NG Market | 2.9% |
Stable Share Price: FIDSON has not had significant price volatility in the past 3 months.
Volatility Over Time: FIDSON's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 650 | Fidelis Ayebae | www.fidson.com |
Fidson Healthcare Plc engages in the manufacture and distribution of pharmaceutical products in Nigeria. The company operates through three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables.
Fidson Healthcare Plc Fundamentals Summary
| FIDSON fundamental statistics | |
|---|---|
| Market cap | ₦36.49b |
| Earnings (TTM) | ₦3.61b |
| Revenue (TTM) | ₦53.05b |
10.1x
P/E Ratio0.7x
P/S RatioIs FIDSON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FIDSON income statement (TTM) | |
|---|---|
| Revenue | ₦53.05b |
| Cost of Revenue | ₦32.26b |
| Gross Profit | ₦20.79b |
| Other Expenses | ₦17.18b |
| Earnings | ₦3.61b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.57 |
| Gross Margin | 39.19% |
| Net Profit Margin | 6.80% |
| Debt/Equity Ratio | 148.0% |
How did FIDSON perform over the long term?
See historical performance and comparisonDividends
3.8%
Current Dividend Yield38%
Payout RatioDoes FIDSON pay a reliable dividends?
See FIDSON dividend history and benchmarks| Fidson Healthcare dividend dates | |
|---|---|
| Ex Dividend Date | Jun 19 2024 |
| Dividend Pay Date | Jul 05 2024 |
| Days until Ex dividend | 60 days |
| Days until Dividend pay date | 76 days |
Does FIDSON pay a reliable dividends?
See FIDSON dividend history and benchmarks